To learn more about the report and hear from advocates leading litigation to secure the protections guaranteed under these new amendments, join our upcoming webinar: Realizing the Promise of State Reproductive Freedom Amendments.

Pre-register at this link: forms.office.com/pages/respon...

Read the full report here! law.ucla.edu/sites/defaul...

They also offer a new approach to constitutionalizing a wider array of reproductive and bodily autonomy rights. Virtually all of the amendments codify rights beyond abortion, including protections explicitly protecting pregnancy decisions and care, birth, family planning, and more.

The amendments represent a powerful shift in the state constitutional landscape. At the time they were passed, more than 50 laws banning or regulating abortion were on the books in these ten states. Already, court decisions in four states have applied the amendments to block abortion restrictions.

These signatories, who are trained and experiences in conducting and evaluating studies on repro issues, including mifepristone, urge FDA to refrain from imposing additional or increased restrictions on mifepristone based on this flawed report. Read the full letter here: law.ucla.edu/sites/defaul...

Through this letter organized by CRHLP and ANSIRH, hundreds of researchers remind the FDA that it’s actions must be based on the sound, rigorous, and transparent science that conclusively proves the safety and effectiveness of mifepristone generally and via telehealth.